跳至主要内容
临床试验/NCT02065843
NCT02065843已完成2 期

Comparative Study of the Effectiveness of Three Anxiolytic Drugs Used in Third Molar Surgery

Universidade Federal de Sergipe1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Changes in anxiety report

研究概览

简要总结

This study was to compare the effectiveness of three drugs (Passiflora incarnata, Erythrina mulungum, Midazolam) in controlling anxiety in patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars.

详细描述

In this research, characterized as a randomized, double-blind, parallel study, 200 healthy volunteered patients aging 18 or older will be distributed into 4 groups (n=50) as follows: Group I - 500mg Erythrina mulungu; Group II - placebo; Group III ; 100 mg Passiflora incarnata; Group IV - 15 mg midazolam. All treatments will be administered p.o. 1 hour randomly prior to the surgical procedures. The level of anxiety will be assessed through questionnaires and physical parameters, such as blood pressure, heart rate and oxygen concentration in three periods: at baseline, right before the surgical procedures and after 7 days. Data will be collected, tabulated and analyzed by the following statistical tests: chi-square, t-test, ANOVA and Tukey test, Friedman, Fisher's exact test with significance level of 5%.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • indication of bilateral extraction of asymptomatic, impacted mandibular third molars

排除标准

  • patients under the age of 18 any general health problem based on the medical history and physical examination history of use of any medication within 15 days before the beginning of the research history of hypersensitivity to drugs, substances or materials used in this experiment pregnancy or lactation history of pericoronitis

研究组 & 干预措施

Mulungu

Active Comparator

500 mg Mulungu Matusa® (Erytrina mulungu, 2 capsules of 250 mg) to be administered v.o., one hour before the surgical procedure.

干预措施: Mulungu (Drug)

placebo

Placebo Comparator

500 mg of starch (2 capsules of 250 mg) to be administered v.o., one hour before the surgical procedure.

干预措施: Placebo (Drug)

Passiflora incarnata

Active Comparator

100 mg Passiflora incarnata (2 capsules of 50 mg) to be administered v.o., one hour before the surgical procedure.

干预措施: Passiflora incarnata (Drug)

midazolam

Active Comparator

15 mg midazolam (2 capsules of 7.5 mg) to be administered v.o., one hour before the surgical procedure.

干预措施: midazolam (Drug)

结局指标

主要结局

Changes in anxiety report

时间窗: Change from baseline to 7 days

Changes in the subjects' anxiety level will be observed by using a Modified Corah Dental Anxiety Scale in three times: at baseline, in the day of surgery and after 7 days of the procedure.

次要结局

  • Changes in blood pressure(Change from baseline to 2 hours)
  • Changes in heart rate(Change from baseline to 2 hours)
  • Changes in oxygen saturation(Change from baseline to 2 hours)

研究者

发起方
Universidade Federal de Sergipe
申办方类型
Other
责任方
Principal Investigator
主要研究者

Liane Maciel de Almeida Souza

Professor

Universidade Federal de Sergipe

研究点 (1)

Loading locations...

相似试验

Three Anxiolytic Drugs Used in Third Molar Surgery | 临床试验